NIDCR will hold a pre-application, technical assistance webinar on March 1, 2023, from 11:00 a.m. to 12:00 p.m. EST for all potential applicants interested in RFA-DE-23-014 - Planning for the TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (R34 Clinical Trial Not Allowed).
Staff from NIDCR, FDA, and NIH Institutes and Offices participating in the FOA will provide an overview of the RFA, including objectives, criteria for responsiveness, and review criteria, and be available to answer application preparation and other relevant questions from prospective applicants.
We request that participants carefully review the funding opportunity for this initiative prior to joining the webinar. Participation in the webinar is optional and is not required for the submission of an application.
To join the webinar, pre-registration is required through the following link: TMD IMPACT Planning RFA Webinar. A recording of the webinar will be posted on this page within 2 weeks of the event.
Participants are encouraged to submit questions in advance to: email@example.com by February 27, 2023. We will prioritize these questions during the Q&A portion of the webinar. While an effort will be made to include all questions in the webinar, it is possible that not all questions will be addressed during the event due to time constraints.